Health Screening


Unless you test, how can you know?

Holsitic Nutritional Review

Reviewing your diet and lifestyle to look for common signs and symptoms of nutrient deficiencies.

BEST testing foods.PNG
Functional Lab Testing & Blood Tests

Functional Testing offers us insight into your physiological and functional health, allowing us to identify change early, long before 'disease' level dysfunctions occur.  We are seeking to maximise health and wellness, reviewing test results from a functional, rather than pathological perspective.


We review general lab test results through your GP from a functional perspective.

  • Cholesterol Subfractions

  • Neurotransmitters

  • Urinary Mercury

  • Salivary Hormones

  • Salivary Stress Hormones

  • Inhalant Allergy Panel

  • Delayed Food Allergen Panel

  • Paediatric Allergy Panel

  • Gluten Sensitivity Testing

  • Mould & Endotoxin Panel

  • Helicobacter

  • Lyme Serology & Blot

  • Comprehensive Digstive Stool Analysis

  • Comprehensive Thryoid Panel

  • Lyme Serology and Western Blot

  • Pfeiffer Protocol Levels

Bioenergetic Food-Stress Testing

Reviewing your diet and lifestyle to look for common signs and symptoms of nutrient deficiencies.

Screening for food-stress responses via distance sessions allow us to review your information


  • wheat

  • gluten

  • diary

  • spelt, kamut

  • vegetables

  • legumes

  • sugar

  • fruits

  • fructose

  • inflammogens

Small Intestine Bacterial Overgrowth Testing (SIBO)

This simple, non–invasive, gastrointestinal test detects bacterial overgrowth in the small intestine, often referred to as BOSI or SIBO. Small intestine bacterial overgrowth (SIBO) is a common gastrointestinal disorder that often underlies chronic gastrointestinal symptoms of maldigestion and malabsorption, including bloating, gas, diarrhea, irregularity, and abdominal pain

Bacterial concentrations in the small intestine are normally kept to a minimum. When excessive, the delicate mucosal lining is disrupted, including the microvilli that facilitate absorption. As a result, bacterial overgrowth of the small intestine (BOSI) can inhibit nutrient absorption and lead to the following serious health problems.

How you can assist once you have a test report for SIBO?

Once bacterial overgrowth has been detected, intervention strategies involving diet, digestive support, probiotics and antimicrobials can be used to treat the condition.

Successful eradication of BOSI has been shown to reduce bloating, gas, diarrhoea, and abdominal pain in patients more effectively than many other treatments for IBS.

Bacterial overgrowth may manifest silently, without overt clinical signs. Patients without clear symptoms of gastrointestinal distress may benefit from testing, especially those with a history of chronic constipation, hypochlorhydria (including use of acid-blocking drugs), or maldigestion.

Common Conditions:

  • Irritable Bowel Syndrome (IBS)

  • Unexplained abdominal symptoms

  • Gas and bloating

  • The inability to tolerate sweet or starchy foods, fibre, or friendly flora supplements

SIBO test sample.PNG

Microbiome Mapping

DNA analysis has transformed the field of microbiology and gut health testing. The Human Microbiome Project and research around the globe have characterized the GI microbiome. More than ever before, we are keenly aware of the health benefits and disease risks brought about by the microorganisms that inhabit the GI tract.

The Complete Microbiome Mapping Test was designed to assess a patient’s microbiome from a single stool sample, with particular attention to microbes that cause disease or that disrupt normal microbial balance and contribute to perturbations in the GI flora and contribute to illness.

The panel is a comprehensive collection of microbial targets as well as immune and digestive markers. It screens for pathogenic bacteria, commensal bacteria, opportunistic pathogens, fungi, viruses, and parasites.

Common Conditions:


  • Abdominal cramps or pain

  • leaky gut symptoms

  • SIBO

  • Allergies

  • Weakness

  • Diarrhoea

  • Bloating

  • Fatigue

microbiome mapping snip 10.21.PNG

Vaginal Microbiome

Vaginal infections, including Bacterial Vaginosis (BV), Vulvovaginal Candidiasis (VVC), and Trichomoniasis Vaginosis (TV) are among the most common reasons for which women seek medical investigation.

Complex ecosystems of microbes reside in the female reproductive tract. The vagina consists of trillions of microorganisms — mostly bacteria, plus some fungi and viruses. A disruption in this ecosystem, usually a deficiency of Lactobacillus and overgrowth of pathogenic bacteria, may result in possible infection and unwanted symptoms.

An estimated 75% of women will have at least one episode of VVC, TV or BV in their lifetime and over 30% of women test positive for BV at any given time, with prevalence rates varying over different populations studied.

The vagina is home to a complex ecosystem of organisms that may include bacteria, viruses, parasites and yeasts. Some of these organisms are important in keeping us healthy as they act to discourage other potential pathogens from thriving. Disruptions in balance of any of these can lead to infections and/or uncomfortable symptoms. Every vaginal microbiome is different and factors such as age, hormonal disruptions and even antibiotic/probiotic use can contribute to changes.

vaginal microbiome test.PNG

Mood Appraisal

This is a great review of your mood that gives a graph visual on what brain chemistry and pathways may need support.


Neurotransmitter Testing (4036)

Testing beyond the standard, limited pathology tests covered by medicare to get a more detailed view of cardiovascular health and wellbeing.

The Neurotransmitter-Advanced Profile is a four point urine analyses test, assessing levels of twelve neurotransmitters which include: Serotonin, GABA, Dopamine, Noradrenaline, Adrenaline, Glutamate, ratio, PEA, Glycine, Histamine, DOPAC, HVA, VMA, and Normetanephrines.

These neurotransmitters communicate with one another in relation to their effects on mood disorders, hormones, sleep, glucose/insulin balance, pain perception, appetite, and cognitive function. The importance of effectively assessing and treating mood disorders cannot be overstated. Objectivity is a key element to the therapeutic approach to mood disorders. Currently, the standard of care dictates a trial and error pharmaceutical approach is taken with each patient based on both self and clinician assessments. However, without information yielded from objective clinical testing, selection of the most effective treatment for each particular patient with a mood disorder continues to be a challenge. While this may prove effective for some patients, the potential for harm during those interim treatment failures is a real concern for clinicians and patients alike.

The report format includes a correlation analysis section, written by the clinical department, which relates the patients’ symptoms with their corresponding lab results, as an aide to the practitioner. Targeted neurotransmitter testing can help health care practitioners achieve a diagnostic edge beyond the traditional psychological inventory by identifying specific imbalances in neurotransmitter levels. Based on neurotransmitter test results, practitioners can identify specific biochemical heterogeneity for each particular patient, and objectively monitor therapeutic responses during and after intervention.

Common Conditions:

  • Depression

  • Anxiety

  • Aggression

  • Poor concentration

  • Poor memory

  • Lack of motivation and energy

  • Mood swings

  • Hyperactivity

  • Thyroid disorders

  • Hormonal Imbalances

  • GIT issues

Neurotransmitter Testing 4036.png

Cardiovascular Health Profiling

Testing beyond the standard, limited pathology tests covered by medicare to get a more detailed view of cardiovascular health and wellbeing.

Cardiovascular profile 1 basic 10.21.PNG

Cholesterol Profiling

Cardiovascular disease (CVD) is one of the leading causes of death worldwide. In the past decade CVD has been the cause of over one-third of all premature deaths in Australia. The conventional risk factors for CVD include hypertension, dyslipidemia, smoking and diabetes mellitus. However, in an individual the presence of only one of these factors has a low positive predictive value. The most advanced strategy for coronary risk assessment is therefore to combine the information of several risk factors; a ‘multi-marker’ approach which enhances risk stratification.

Being one of the leading causes of death worldwide, more years of potential life before the age of 75 are lost due to this disease than any other human condition. Fortunately, over the past thirty years significant progress has been made in the areas of diagnosis, prevention and treatment of CVD. One of the most critical advances has been the identification of the major risk factors for CVD which arose from studies such as the Framingham Heart Study and the Seven Countries Study.

The conventional risk factors for CVD include hypertension, smoking, diabetes mellitus, hypercholesterolaemia, hypertriglyceridaemia and low HDL cholesterol. However, in an individual the presence of only one of these factors has a low positive predictive value. Furthermore, a significant number of cardiovascular events still occur in individuals without these established risk indicators. At present, the most advanced strategy for coronary risk assessment is therefore to combine the information of several risk factors. This multi-marker approach can enhance risk stratification, identifying those individuals with a moderate baseline risk who might benefit from aggressive risk reduction strategies. Not only are conventional risk factors assessed, but other CVD biomarkers such as lipoprotein (a), apolipoproteins A & B, homocysteine, fibrinogen and C-reactive protein (CRP) are included.

Common Conditions:

  • Hypercholesterolemia

  • Insulin resistance

  • Diabetes

  • Cardiovascular disease

  • Statin therapy

  • Menopause

  • Obesity, metabolic syndrome

& much more.